?Cancer Center Administration The Office of Administration is the organizational hub that advances and supports the activities of the St. Jude Comprehensive Cancer Center (SJCCC). It provides resources and expertise to facilitate the initiatives and ongoing operations of the Center, including providing the crucial organizational structure and support to enable leadership to bring to life a robust 8-goal SJCCC strategic plan in the current project period. The administrative team is led by Ms. Dana Wallace, Associate Director for Administration, who directs and facilitates all processes for strategic planning and oversees all operations of the Office of Administration. Ms. Wallace is joined by a team of expert administrators and works closely with the SJCCC Director, Associate Directors, Program Co-Leaders, and Shared Resource Directors to plan and execute the strategic goals of the Center, fiscally manage the CCSG and provide comprehensive administrative oversight and support for the Center. Administration effectively oversees the CCSG application process and ensures accurate, comprehensive reporting; manages and tracks membership processes; and manages space, budgets, pilot awards, and Shared Resources to fully support Center members in advancing their research programs. Administration also organizes and supports meetings, strategic plan working groups, and other forums to promote transdisciplinary team science within the SJCCC and with external investigators. During the current project period, Administration worked with the Center Director to develop and execute the year-long strategic planning process that involved all members of the SJCCC, 4 retreats, and numerous follow-up meetings, ultimately leading to 8 strategic goals that expand Center capabilities, exciting new research areas, and outreach and career enhancement activities. Administration also planned and operationalized changes in membership policy to ensure support of a cancer research-centric membership, developed proposals for Leadership consideration to implement recommendations from the SJCCC advisory committees, and planned, developed, and administratively supported substantial new initiatives in community engagement and outreach such as the St. Jude Science Scholars of Tomorrow Symposium and HPV Awareness Task Force. During this period, the SJCCC Office of Administration increased by 3 FTEs to accommodate the increased activities generated by strategic planning and the vision of the Center Director. Future plans include further growth in administrative staff to support ongoing growth of Center activities, and building upon the current processes for strategic plan implementation in collaboration with the Director and Senior Leadership, with a focus on developing and implementing action plans to accelerate progress. We will also support SJCCC members in competing for extramural funds by identifying and communicating relevant funding opportunities and organizing training activities to complement our successful grant-writing workshops. Through these efforts, Center Administration provides support for the SJCCC and its members in our shared mission of advancing research and cures for pediatric cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA021765-40
Application #
9632002
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-03-01
Budget End
2020-02-29
Support Year
40
Fiscal Year
2019
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Shadrick, William R; Slavish, Peter J; Chai, Sergio C et al. (2018) Exploiting a water network to achieve enthalpy-driven, bromodomain-selective BET inhibitors. Bioorg Med Chem 26:25-36
Ramsey, Laura B; Balis, Frank M; O'Brien, Maureen M et al. (2018) Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance. Oncologist 23:52-61
Churchman, Michelle L; Qian, Maoxiang; Te Kronnie, Geertruy et al. (2018) Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia. Cancer Cell 33:937-948.e8
Hatfield, M Jason; Binder, Randall J; Gannon, Rowan et al. (2018) Potent, Irreversible Inhibition of Human Carboxylesterases by Tanshinone Anhydrides Isolated from Salvia miltiorrhiza (""Danshen""). J Nat Prod 81:2410-2418
Vo, BaoHan T; Kwon, Jin Ah; Li, Chunliang et al. (2018) Mouse medulloblastoma driven by CRISPR activation of cellular Myc. Sci Rep 8:8733
Drummond, Catherine J; Hanna, Jason A; Garcia, Matthew R et al. (2018) Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors. Cancer Cell 33:108-124.e5
Jones, Conor M; Baker, Justin N; Keesey, Rachel M et al. (2018) Importance ratings on patient-reported outcome items for survivorship care: comparison between pediatric cancer survivors, parents, and clinicians. Qual Life Res 27:1877-1884
Huang, I-Chan; Brinkman, Tara M; Mullins, Larry et al. (2018) Child symptoms, parent behaviors, and family strain in long-term survivors of childhood acute lymphoblastic leukemia. Psychooncology 27:2031-2038
Huang, I-Chan; Klosky, James L; Young, Chelsea M et al. (2018) Misclassification of self-reported smoking in adult survivors of childhood cancer. Pediatr Blood Cancer 65:e27240
Mandrell, Belinda N; Avent, Yvonne; Walker, Breya et al. (2018) In-home salivary melatonin collection: Methodology for children and adolescents. Dev Psychobiol 60:118-122

Showing the most recent 10 out of 6764 publications